Thousands of cancer patients are being denied drugs that could extend their lives because of restrictions on supplying medications outside their licensed use, campaigners say.
Almost 3,200 patients have been forced to plead for funding from the NHS for so-called “near-label” treatments – medicines licensed for use in some cancers, but not in other, similar forms of the disease.
In the past three years, 1,053 applications for funding were rejected by local primary care trusts (PCTs), meaning that patients had either to go without or pay up to £20,000 for treatment.
The figures, uncovered through Freedom of Information requests to every PCT in England, are published today by the Rarer Cancers Forum.
This is England folks and I could very well be us if Obama Care is rushed in to law. Our issues should be looking at tort reform and being able to shop state to state for plans to bring down the insurance costs.
Why do people from other countries attending our medical institutions? Our doctors do charitable work all over the globe to help those in need, no one tell them that they have to, yet..